Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging - 28/08/14
Doi : 10.1016/j.echo.2014.07.012
Juan Carlos Plana, MD, FASE, Chair a, Maurizio Galderisi, MD, FESC, Co-Chair b, Ana Barac, MD, PhD c, Michael S. Ewer, MD, JD d, Bonnie Ky, MD, FASE e, Marielle Scherrer-Crosbie, MD, PhD, FASE f, Javier Ganame, MD, PhD, FASE g, Igal A. Sebag, MD, FASE h, Deborah A. Agler, RCT, RDCS, FASE a, Luigi P. Badano, MD, PhD, FESC i, Jose Banchs, MD, FASE d, Daniela Cardinale, MD, PhD, FESC j, Joseph Carver, MD k, Manuel Cerqueira, MD a, Jeanne M. DeCara, MD, FASE l, Thor Edvardsen, MD, PhD, FESC m, Scott D. Flamm, MD, MBA a, Thomas Force, MD n, Brian P. Griffin, MD a, Guy Jerusalem, MD, PhD o, Jennifer E. Liu, MD, FASE p, Andreia Magalhães, MD q, Thomas Marwick, MBBS, PhD, MPH r, Liza Y. Sanchez, RCS, FASE d, Rosa Sicari, MD, PhD, FESC s, Hector R. Villarraga, MD, FASE t, Patrizio Lancellotti, MD, PhD, FESC o
a Cleveland Clinic, Cleveland, Ohio
b Federico II University Hospital, Naples, Italy
c Medstar Washington Hospital Center, Washington, District of Columbia
d MD Anderson Cancer Center, University of Texas, Houston, Texas
e University of Pennsylvania, Philadelphia, Pennsylvania
f Massachusetts General Hospital, Boston, Massachusetts
g McMaster University, Hamilton, Ontario, Canada
h Jewish General Hospital and McGill University, Montreal, Quebec, Canada
i University of Padua, Padua, Italy
j European Institute of Oncology, Milan, Italy
k Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania
l University of Chicago Medicine, Chicago, Illinois
m Oslo University Hospital and University of Oslo, Oslo, Norway
n Temple University, Philadelphia, Pennsylvania
o University of Liege, Liege, Belgium
p Memorial Sloan-Kettering Cancer Center, New York, New York
q Santa Marie University Hospital, Lisbon, Portugal
r Menzies Research Institute Tasmania, Hobart, Australia
s CNR Institute of Clinical Physiology, Pisa, Italy
t Mayo Clinic, Rochester, Minnesota
Abstract |
Le texte complet de cet article est disponible en PDF.
Keywords : Chemotherapy, Doxorubicin, Trastuzumab, Left ventricular dysfunction, Three-dimensional echocardiography, Early detection, Strain, Biomarkers
Abbreviations : ASE, BNP, CAD, CMR, CTRCD, DTI, EACVI, EAE, GLS, HF, LGE, LV, LVEF, MUGA, NT-proBNP, RV, STE, 3D, 3DE, TnI, 2D, 2DE, VEGF
Plan
| The following authors reported no actual or potential conflicts of interest in relation to this document: Juan Carlos Plana, MD, FASE, Maurizio Galderisi, MD, FESC, Marielle Scherrer-Crosbie, MD, PhD, FASE, Javier Ganame, MD, PhD, FASE, Deborah A. Agler, RCT, RDCS, FASE, Luigi P. Badano, MD, PhD, FESC, Jose Banchs, MD, FASE, Daniela Cardinale, MD, Joseph Carver, MD, Thor Edvardsen, MD, PhD, FESC, Brian Griffin, MD, Guy Jerusalem, MD, PhD, Jennifer E. Liu, MD, FASE, Andreia Magalhães, MD, Liza Y. Sanchez, RCS, FASE, Rosa Sicari, MD, PhD, FESC, Hector R. Villarraga, MD, FASE, and Patrizio Lancellotti, MD, PhD, FESC. The following authors reported relationships with one or more commercial interests: Ana Barac, MD, received research funding and lectures honoraria from Genentech and consultancy fees from Cell Therapeutics. Manuel Cerqueira, MD, received a grant from Perceptive Informatics, Inc; consults for GE Healthcare, FluoroPharma and Astellas; and serves on the speakers bureau for Astellas. Jeanne M. DeCara, MD, served as a consultant for Epsilon Imaging and Methylgene. Michael S. Ewer, MD, JD, consults or serves as advisory board member for Roche Laboratories, Cell Therapeutics, GlaxoSmithKline, and Boehringer Ingelheim. Scott D. Flamm, MD, MBA, serves on advisory boards for Philips Healthcare, Bayer Healthcare, and TeraRecon and received institutional research support from Siemens Healthcare. Thomas Force, MD consults for GlaxoSmithKline. Bonnie Ky, MD, FASE, received an investigator-initiated award from Pfizer, Inc. Thomas Marwick, MBBS, PhD, MPH, received research funding from the National Health and Medical Research Council in Australia and the Royal Hobart Hospital Foundation, an equipment grant from Philips Medical Systems and Siemens, and a project grant from GE Medical Systems. Igal A. Sebag, MD, FASE, serves on the speakers bureau for Lantheus. |
|
| Reprint requests: American Society of Echocardiography, 2100 Gateway Centre Boulevard, Suite 310, Morrisville, NC 27560 (E-mail: ase@asecho.org). |
© 2014
Publié par Elsevier Masson SAS.
Vol 27 - N° 9
P. 911-939 - septembre 2014 Retour au numéro
Article précédent
- Information for Readers
- Echocardiography: Profiling of the Athlete’s Heart
- Timothy E. Paterick, Tia Gordon, Denise Spiegel
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?